A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
Clinical trial NCT04715646 · RECRUITING
Trial details
- NCT number
- NCT04715646
- Sponsor
- UCB Biopharma SRL
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-11
- Primary completion
- 2030-07-08
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.